Endothelin-1 receptor a blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats

Hepatology

Volumn 59, Issue 3, 2014, Pages 1107-1117

  Bahde, Ralf ^a,b   Kapoor, Sorabh ^a   Viswanathan, Preeti ^a   Spiegel, Hans Ullrich ^b   Gupta, Sanjeev ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DARUSENTAN; DIPEPTIDYL PEPTIDASE IV; RETRORSINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM INJURY; ENGRAFTMENT; FISCHER 344 RAT; GENE EXPRESSION; HEPATOCYTE TRANSPLANTATION; IN VITRO STUDY; INFLAMMATION; KUPFFER CELL; LIVER CELL; LIVER ISCHEMIA; LIVER PARENCHYMA; LIVER TRANSPLANTATION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; STELLATE CELL; VASODILATATION;

ANIMALS; CELL TRANSPLANTATION; DIPEPTIDYL PEPTIDASE 4; HEPATECTOMY; HEPATIC STELLATE CELLS; HEPATOCYTES; ISCHEMIA; KUPFFER CELLS; LIVER; LIVER CIRCULATION; LIVER REGENERATION; NEUTROPHILS; PHENYLPROPIONATES; PYRIMIDINES; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; RECEPTOR, ENDOTHELIN A; TRANSCRIPTOME; VASODILATION;

EID: 84896705394     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26766     Document Type: Article

References (22)

1. Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ 3rd, Kolansky DM, et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 1996;223:116-126.
2. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-1426.
3. Bahde R, Kapoor S, Bandi S, Bhargava K, Palestro C, Gupta S. Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rat liver. Hepatology 2013;57:320-330.
4. Krohn N, Kapoor S, Enami Y, Follenzi A, Bandi S, Joseph B, Gupta S. Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells. Gastroenterology 2009;136:1806-1817.
5. Enami Y, Bandi S, Kapoor S, Krohn N, Joseph B, Gupta S. Hepatic stellate cells promote hepatocyte engraftment in rat liver after prostaglin-endoperoxidase synthase inhibition. Gastroenterology 2009;136:2356-2364.
6. Gustafson EK, Elgue G, Hughes RD, Mitry RR, Sanchez J, Haglund U, et al. The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation 2011;91:632-638.
7. Gupta S, Rajvanshi P, Sokhi RP, Slehria S, Yam A, Kerr A, Novikoff PM. Entry and integration of transplanted hepatocytes in liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 1999;29:509-519.
8. Joseph B, Kumaran V, Berishvili E, Bhargava KK, Palestro CJ, Gupta S. Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning. Hepatology 2006;44:1411-1420.
9. Slehria S, Rajvanshi P, Ito Y, Sokhi RP, Bhargava KK, Palestro CS, et al. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver. Hepatology 2002;35:1320-1328.
10. Kuc RE, Maguire JJ, Davenport AP. Quantification of endothelin receptor subtypes in peripheral tissues reveals downregulation of ET(A) receptors in ET(B)-deficient mice. Exp Biol Med 2006;231:741-745.
11. Rapoport RM, Zuccarello M. Endothelin(A)-endothelin(B) receptor cross-talk and endothelin receptor binding. J Pharm Pharmacol 2011;63:1373-1377.
12. Ohkita M, Takaoka M, Matsumura Y. Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD. J Pharmacol Sci 2009;109:7-13.
13. Lazich I, Bakris GL. Endothelin antagonism in patients with resistant hypertension and hypertension nephropathy. Contrib Nephrol 2011;172:223-234.
14. Palmes D, Skawran S, Stratmann U, Armann B, Minin E, Herbst H, Spiegel HU. Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure. J Hepatol 2005;42:350-357.
15. Palmes D, Minin E, Budny T, Uhlmann D, Armann B, Stratmann U, et al. The endothelin/nitric oxide balance determines small-for-size liver injury after reduced-size rat liver transplantation. Virchows Arch 2005;447:731-741.
16. Prié S, Stewart DJ, Dupuis J. EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension. Circulation 1998;97:2169-2174.
17. Epstein BJ. Efficacy and safety of darusentan: a novel endothelin receptor antagonist. Ann Pharmacother 2008;42:1060-1069.
18. Gupta S, Rajvanshi P, Malhi H, Sokhi RP, Slehria S, Vasa SRG, et al. Cell transplantation causes loss of gap junctions and activates GGT expression permanently in host liver. Am J Physiol Gastroint Liver Physiol 2000;279:G815-G826.
19. Liang F, Glascock CB, Schafer DL, Sandoval J, Cable L, Melvin L, Jr., et al. Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries. Can J Physiol Pharmacol 2010;88:840-849.
20. Watanabe N, Takashimizu S, Nishizaki Y, Kojima S, Kagawa T, Matsuzaki S. An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications of endothelin-1 in hepatic microcirculation. J Gastroenterol 2007;42:775-782.
21. Simonson MS, Ismail-Beigi F. Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J Biol Chem 2011;286:11003-11008.
22. Lattmann T, Hein M, Horber S, Ortmann J, Teixeira MM, Souza DG, et al. Activation of pro-inflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling. Am J Transplant 2005;5:1042-1049.